These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 3332506)
1. The use of immunofluorescence to evaluate the efficacy of malarial chemoprophylaxis. Myint Lwin ; Kyaw Win ; Ye Htut ; Ye Thwe ; Tin Thein Lwin ; Khin Win Trans R Soc Trop Med Hyg; 1987; 81(6):896-8. PubMed ID: 3332506 [TBL] [Abstract][Full Text] [Related]
2. Combination of mefloquine with sulfadoxine-pyrimethamine compared with two sulfadoxine-pyrimethamine combinations in malaria chemoprophylaxis. Win K; Thwe Y; Lwin TT; Win K Lancet; 1985 Sep; 2(8457):694-5. PubMed ID: 2863679 [No Abstract] [Full Text] [Related]
3. Double-blind trial to find dose range using a fixed combination of mefloquine, sulfadoxine and pyrimethamine in falciparum malaria: a field study on adults in Burma. Tin F; Nyunt Hlaing ; Lim MA; Win S; Lasserre R Trans R Soc Trop Med Hyg; 1987; 81(6):910-2. PubMed ID: 3332509 [TBL] [Abstract][Full Text] [Related]
4. Double-blind dose finding study of mefloquine-sulfadoxine-pyrimethamine in children with acute falciparum malaria. Guo XB; Arnold K; Fu LC; Chen PQ; Li GQ Trans R Soc Trop Med Hyg; 1988; 82(4):538-40. PubMed ID: 3076709 [TBL] [Abstract][Full Text] [Related]
5. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria. Botero D; Restrepo M; Montoya A Bull World Health Organ; 1985; 63(4):731-7. PubMed ID: 3910296 [TBL] [Abstract][Full Text] [Related]
6. Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria. Kollaritsch H; Stemberger H; Mailer H; Kremsner P; Kollaritsch R; Leimer R; Wiedermann G Trans R Soc Trop Med Hyg; 1988; 82(4):524-9. PubMed ID: 2908258 [TBL] [Abstract][Full Text] [Related]
7. A phase I clinical trial of mefloquine in Brazilian male subjects. de Souza JM Bull World Health Organ; 1983; 61(5):809-14. PubMed ID: 6360400 [TBL] [Abstract][Full Text] [Related]
8. A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria. Ekue JM; Simooya OO; Sheth UK; Wernsdorfer WH; Njelesani EK Bull World Health Organ; 1985; 63(2):339-43. PubMed ID: 3893778 [TBL] [Abstract][Full Text] [Related]
9. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria. Ekue JM; Phiri DE; Sheth UK; Mukunyandela M Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440 [TBL] [Abstract][Full Text] [Related]
10. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria. de Souza JM; Sheth UK; Wernsdorfer WH; Trigg PI; Doberstyn EB Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438 [TBL] [Abstract][Full Text] [Related]
11. Plasmodium falciparum resistant to mefloquine plus sulfadoxine/pyrimethamine. Heizmann P; Fernex M; Leimer R; Reber-Liske R; Stohler H Lancet; 1986 Feb; 1(8477):377. PubMed ID: 2868309 [No Abstract] [Full Text] [Related]
12. Single-dose therapy of falciparum malaria with mefloquine or pyrimethamine-sulfadoxine. Doberstyn EB; Phintuyothin P; Noeypatimanondh S; Teerakiartkamjorn C Bull World Health Organ; 1979; 57(2):275-9. PubMed ID: 373903 [TBL] [Abstract][Full Text] [Related]
13. Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose. Harinasuta T; Bunnag D; Vanijanond S; Charoenlarp P; Suntharasmai P; Chitamas S; Sheth UK; Wernsdorfer WH Bull World Health Organ; 1987; 65(3):363-7. PubMed ID: 3311439 [TBL] [Abstract][Full Text] [Related]
14. A phase II clinical trial of mefloquine in Brazilian male subjects. de Souza JM Bull World Health Organ; 1983; 61(5):815-20. PubMed ID: 6360401 [TBL] [Abstract][Full Text] [Related]
15. An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil. de Souza JM; Sheth UK; de Oliveira RM; Roulet H; de Souza SD Bull World Health Organ; 1985; 63(3):603-9. PubMed ID: 3899397 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of mefloquine in combination with sulfadoxine-pyrimethamine and primaquine in male Thai patients with falciparum malaria. Karbwang J; Back DJ; Bunnag D; Breckenridge AM Bull World Health Organ; 1990; 68(5):633-8. PubMed ID: 2289299 [TBL] [Abstract][Full Text] [Related]
17. Malaria on the Thai-Burmese border: treatment of 5192 patients with mefloquine-sulfadoxine-pyrimethamine. Nosten F; Imvithaya S; Vincenti M; Delmas G; Lebihan G; Hausler B; White N Bull World Health Organ; 1987; 65(6):891-6. PubMed ID: 3325187 [TBL] [Abstract][Full Text] [Related]
18. [Malaria in Switzerland]. Fernex M Schweiz Med Wochenschr; 1988 Dec; 118(49):1838-43. PubMed ID: 3064291 [TBL] [Abstract][Full Text] [Related]
19. Combination treatment for falciparum prophylaxis. White NJ Lancet; 1987 Mar; 1(8534):680-1. PubMed ID: 2882095 [No Abstract] [Full Text] [Related]
20. Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria. Hall AP; Doberstyn EB; Karnchanachetanee C; Samransamruajkit S; Laixuthai B; Pearlman EJ; Lampe RM; Miller CF; Phintuyothin P Br Med J; 1977 Jun; 1(6077):1626-8. PubMed ID: 326337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]